LEGN
Legend Biotech Corp
18.80$
+1.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -110.6% | – | – | – | – | – | -466.8% | – | – | – | |
| – | +3.5% | +6.9% | -6.2% | -27.2% | +73.9% | -23.5% | +12.6% | +0.4% | +104.5% | +30.2% | -25.2% | – | |
| – | +1.7% | +48.6% | +16.2% | -30.5% | -11.4% | +19.1% | +17.3% | -19.7% | -0.5% | +29.2% | -10.4% | – | |
| – | – | – | -96.8% | -33.4% | -4,117.9% | – | – | – | -140.6% | – | – | – | |
| – | +25.1% | -8.8% | -45.3% | -39.6% | +15.2% | -15.8% | +360.7% | -45.7% | +317.9% | +24.2% | -20.6% | – | |
| – | – | -197.2% | +75.6% | – | -126.7% | – | -164.5% | -87.9% | – | -126.3% | -28.8% | – | |
| – | – | – | – | – | -19.6% | -17.0% | +62.5% | -52.3% | +59.1% | +35.7% | +3,353.8% | – | |
| – | -3.7% | -10.2% | +14.9% | +344.5% | -107.8% | – | -248.4% | – | -196.8% | +85.6% | – | – | |
| – | – | -221.0% | – | – | -166.9% | – | -213.0% | – | +4,961.7% | -141.0% | – | – | |
| – | – | – | -154.7% | – | – | – | – | – | -631.9% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.